Noticias de SVRA_US

Noticias del mercado

Últimas noticias sobre SVRA_US — 133 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: SVRA_US ✕ 133 resultados
06/03/2026 SVRA_US — Investing.com ES ← EN
Savara recibe carta del día 74 de la FDA sobre medicamento autoinmune para PAP
06/03/2026 SVRA_US — Yahoo Finance
Savara Provides Regulatory Update on the MOLBREEVI* Development Program in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)
04/03/2026 SVRA_US — Yahoo Finance
Savara Announces Participation in 2026 Citizens Life Sciences Conference
04/03/2026 SVRA_US — Business Wire
Savara Announces Participation in 2026 Citizens Life Sciences Conference
03/03/2026 SVRA_US — MyChesCo
Savara’s MOLBREEVI BLA Receives FDA Priority Review
01/03/2026 SVRA_US — Yahoo Finance
Savara Highlights FDA Priority Review for Molbreevi as Aug. 22 PDUFA Date Nears
28/02/2026 SVRA_US — Kavout
What Does the FDA's Priority Review Mean for Savara's MOLBREEVI
23/02/2026 SVRA_US — Investing.com
Citizens reiterates Savara stock rating on likely FDA approval
20/02/2026 SVRA_US — Yahoo Finance
Savara Announces the U.S. Food and Drug Administration (FDA) Filed the MOLBREEVI* Biologics License Application (BLA) in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)
20/02/2026 SVRA_US — Investing.com
FDA accepts Savara’s drug application for rare lung disease By Investing.com
20/02/2026 SVRA_US — Business Wire
Savara Announces the U.S. Food and Drug Administration (FDA) Filed the MOLBREEVI* Biologics License Application (BLA) in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)
15/02/2026 SVRA_US — BioSpace
Savara Announces New Employment Inducement Grant - February 13, 2026
14/02/2026 SVRA_US — Stock Titan
SVRA Financials: Income Statement, Balance Sheet & Cash Flow

Página 7 de 7

keyboard_arrow_up